The SCLC component showed higher positive rates for synaptophysin, CD56, ASCL1, and INSM1, and a higher labeling index for Ki67 compared to the NSCLC component (Table 2 and Figure S1). Here, ASCL1 is linked to non-small cell lung carcinoma.